No effect of the transforming growth factor β1 promoter polymorphism C-509T on TGFB1 gene expression, protein secretion, or cellular radiosensitivity
Copyright © 2013 Elsevier Inc. All rights reserved..
PURPOSE: To study whether the promoter polymorphism (C-509T) affects transforming growth factor β1 gene (TGFB1) expression, protein secretion, and/or cellular radiosensitivity for both human lymphocytes and fibroblasts.
METHODS AND MATERIALS: Experiments were performed with lymphocytes taken either from 124 breast cancer patients or 59 pairs of normal monozygotic twins. We used 15 normal human primary fibroblast strains as controls. The C-509T genotype was determined by polymerase chain reaction-restriction fragment length polymorphism or TaqMan single nucleotide polymorphism (SNP) genotyping assay. The cellular radiosensitivity of lymphocytes was measured by G0/1 assay and that of fibroblasts by colony assay. The amount of extracellular TGFB1 protein was determined by enzyme-linked immunosorbent assay, and TGFB1 expression was assessed via microarray analysis or reverse transcription-polymerase chain reaction.
RESULTS: The C-509T genotype was found not to be associated with cellular radiosensitivity, neither for lymphocytes (breast cancer patients, P=.811; healthy donors, P=.181) nor for fibroblasts (P=.589). Both TGFB1 expression and TGFB1 protein secretion showed considerable variation, which, however, did not depend on the C-509T genotype (protein secretion: P=.879; gene expression: lymphocytes, P=.134, fibroblasts, P=.605). There was also no general correlation between TGFB1 expression and cellular radiosensitivity (lymphocytes, P=.632; fibroblasts, P=.573).
CONCLUSION: Our data indicate that any association between the SNP C-509T of TGFB1 and risk of normal tissue toxicity cannot be ascribed to a functional consequence of this SNP, either on the level of gene expression, protein secretion, or cellular radiosensitivity.
Errataetall: |
CommentIn: Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):400-1. - PMID 23708081 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2013 |
---|---|
Erschienen: |
2013 |
Enthalten in: |
Zur Gesamtaufnahme - volume:85 |
---|---|
Enthalten in: |
International journal of radiation oncology, biology, physics - 85(2013), 2 vom: 01. Feb., Seite 460-5 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Reuther, Sebastian [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Completed 17.03.2013 Date Revised 11.07.2013 published: Print-Electronic CommentIn: Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):400-1. - PMID 23708081 Citation Status MEDLINE |
---|
doi: |
10.1016/j.ijrobp.2012.01.090 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM217847943 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM217847943 | ||
003 | DE-627 | ||
005 | 20231224035021.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2013 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ijrobp.2012.01.090 |2 doi | |
028 | 5 | 2 | |a pubmed24n0726.xml |
035 | |a (DE-627)NLM217847943 | ||
035 | |a (NLM)22592044 | ||
035 | |a (PII)S0360-3016(12)00200-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Reuther, Sebastian |e verfasserin |4 aut | |
245 | 1 | 0 | |a No effect of the transforming growth factor β1 promoter polymorphism C-509T on TGFB1 gene expression, protein secretion, or cellular radiosensitivity |
264 | 1 | |c 2013 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.03.2013 | ||
500 | |a Date Revised 11.07.2013 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentIn: Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):400-1. - PMID 23708081 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2013 Elsevier Inc. All rights reserved. | ||
520 | |a PURPOSE: To study whether the promoter polymorphism (C-509T) affects transforming growth factor β1 gene (TGFB1) expression, protein secretion, and/or cellular radiosensitivity for both human lymphocytes and fibroblasts | ||
520 | |a METHODS AND MATERIALS: Experiments were performed with lymphocytes taken either from 124 breast cancer patients or 59 pairs of normal monozygotic twins. We used 15 normal human primary fibroblast strains as controls. The C-509T genotype was determined by polymerase chain reaction-restriction fragment length polymorphism or TaqMan single nucleotide polymorphism (SNP) genotyping assay. The cellular radiosensitivity of lymphocytes was measured by G0/1 assay and that of fibroblasts by colony assay. The amount of extracellular TGFB1 protein was determined by enzyme-linked immunosorbent assay, and TGFB1 expression was assessed via microarray analysis or reverse transcription-polymerase chain reaction | ||
520 | |a RESULTS: The C-509T genotype was found not to be associated with cellular radiosensitivity, neither for lymphocytes (breast cancer patients, P=.811; healthy donors, P=.181) nor for fibroblasts (P=.589). Both TGFB1 expression and TGFB1 protein secretion showed considerable variation, which, however, did not depend on the C-509T genotype (protein secretion: P=.879; gene expression: lymphocytes, P=.134, fibroblasts, P=.605). There was also no general correlation between TGFB1 expression and cellular radiosensitivity (lymphocytes, P=.632; fibroblasts, P=.573) | ||
520 | |a CONCLUSION: Our data indicate that any association between the SNP C-509T of TGFB1 and risk of normal tissue toxicity cannot be ascribed to a functional consequence of this SNP, either on the level of gene expression, protein secretion, or cellular radiosensitivity | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Transforming Growth Factor beta1 |2 NLM | |
700 | 1 | |a Metzke, Elisabeth |e verfasserin |4 aut | |
700 | 1 | |a Bonin, Michael |e verfasserin |4 aut | |
700 | 1 | |a Petersen, Cordula |e verfasserin |4 aut | |
700 | 1 | |a Dikomey, Ekkehard |e verfasserin |4 aut | |
700 | 1 | |a Raabe, Annette |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of radiation oncology, biology, physics |d 1983 |g 85(2013), 2 vom: 01. Feb., Seite 460-5 |w (DE-627)NLM000375381 |x 1879-355X |7 nnns |
773 | 1 | 8 | |g volume:85 |g year:2013 |g number:2 |g day:01 |g month:02 |g pages:460-5 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijrobp.2012.01.090 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 85 |j 2013 |e 2 |b 01 |c 02 |h 460-5 |